Equity Pricing in the Real World: Moving from Ambiguity to Action for Patients, Payers, and Health Systems Aligning equitable access and commercial sustainability is one of the Read More »
Optimize your evidence plan How an early payer value narrative informed the evidence generation plan for an innovative therapy targeting a metabolic disease Read More
Optimize your evidence plan How a deep understanding of CDx pricing and reimbursement informed strategic R&D decision-making Read More
Optimize your evidence plan How creating a unified vision and comprehensive framework for Real-World Evidence (RWE) supported seamless execution of RWE projects Read More
Optimize your evidence plan How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
